Journal of controlled release : official journal of the Controlled Release Society

Using AI to quickly design and improve fat-based particles for delivering medicine

Updated

Abstract

Lipid nanoparticles (LNPs) are highlighted as promising vehicles for drug delivery.

  • Specific design and optimization of LNPs is necessary to maximize therapeutic effects for various diseases.
  • High-throughput technology can generate large-scale datasets essential for understanding LNP characteristics.
  • Artificial intelligence (AI) has the potential to connect biological attributes with LNP structures by analyzing experimental data.
  • AI-assisted approaches may streamline the discovery and optimization processes of LNPs.
  • The review discusses the creation of datasets for AI training and the implications for future clinical applications of LNPs.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free